Comparison
22q Partial Monosomy C0265489 vs 11p15 4 Microduplication Syndrome C4749508
Clinical comparison between 22q Partial Monosomy and 11p15 4 Microduplication Syndrome for differential diagnosis and treatment planning.
22q Partial Monosomy C0265489
A genetic disorder from missing material on chromosome 22, often called DiGeorge syndrome. It can affect the heart, immune system, and development. Requires lifelong specialized medical care.
11p15 4 Microduplication Syndrome C4749508
A rare genetic disorder involving duplication of material on chromosome 11, leading to varied developmental features. Requires individualized medical assessment.
6 comparison axes
Onset
22q Partial Monosomy C0265489
0-null
11p15 4 Microduplication Syndrome C4749508
0-null
Onset patterns differ
Severity
22q Partial Monosomy C0265489
severe
11p15 4 Microduplication Syndrome C4749508
moderate
Different severity levels
Chronic
22q Partial Monosomy C0265489
Chronic
11p15 4 Microduplication Syndrome C4749508
Chronic
Differing course
Communicable
22q Partial Monosomy C0265489
No
11p15 4 Microduplication Syndrome C4749508
No
Different transmission
Body System
22q Partial Monosomy C0265489
congenital
11p15 4 Microduplication Syndrome C4749508
congenital
Same/different system
Category
22q Partial Monosomy C0265489
rare-disease
11p15 4 Microduplication Syndrome C4749508
genetic
Different category
Bottom line
22q-partial-monosomy-C0265489 and 11p15-4-microduplication-syndrome-C4749508 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 22q Partial Monosomy C0265489 | 11p15 4 Microduplication Syndrome C4749508 | Discriminating power |
|---|---|---|---|
| Congenital anomalies | May include cardiac, palatal, immune, calcium, or developmental findings, depending on deleted region. | Reported features vary; a consistent anomaly pattern is not established. | Moderate |
| Development | Developmental delay or learning differences may occur but are not universal. | Developmental features are described as variable; severity is not established. | Low |
| Immune or endocrine clues | Immune dysfunction or hypocalcemia can occur in some 22q-related presentations. | No characteristic immune or endocrine pattern is established from the supplied data. | Moderate |
When to favor each condition
Choose 22q Partial Monosomy C0265489 when
A chromosomal test shows missing chromosome 22 material
The genetic result, including breakpoints and size, defines this finding.
High
Cardiac, palatal, immune, or calcium abnormalities suggest 22q spectrum
These clues support targeted testing but do not prove the diagnosis alone.
Moderate
Family history includes a confirmed chromosome 22 deletion
This raises suspicion and warrants genetics evaluation.
Moderate
Choose 11p15 4 Microduplication Syndrome C4749508 when
Microarray identifies duplication at 11p15.4
The specific genomic result is required to establish this rare finding.
High
Developmental features are present without a characteristic syndrome pattern
Broad genetic testing may be more appropriate than assuming a 22q disorder.
Moderate
A relative has a confirmed 11p15.4 duplication
Targeted familial testing can be considered after genetics counseling.
Moderate
How key tests differ
| Test | 22q Partial Monosomy C0265489 | 11p15 4 Microduplication Syndrome C4749508 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect a deletion involving chromosome 22. | May detect a duplication at 11p15.4. | Location, size, and gene content require laboratory and clinical interpretation. |
| Targeted 22q11.2 testing | FISH, MLPA, or comparable testing may identify a relevant deletion. | Not expected to identify an 11p15.4 duplication. | A negative targeted test does not exclude other chromosomal changes. |
| Organ-system evaluation | Heart, immune, calcium, palate, hearing, and development assessments may be indicated. | Evaluation should be individualized because characteristic abnormalities are not established. | Abnormal results are clinical findings, not proof of either genetic condition. |
Prognosis comparison
22q Partial Monosomy C0265489
- Outcome
- Often chronic and potentially severe, but outcome varies with affected organs and available care.
- Factors
- Cardiac, immune, endocrine, developmental, and deletion-specific findings.
11p15 4 Microduplication Syndrome C4749508
- Outcome
- Described as moderate but variable; reliable outcome data are not established.
- Factors
- Duplication size, gene content, developmental findings, and associated anomalies.
Time frame: Congenital and potentially lifelong; exact course cannot be predicted from these data.
Precise genetic result, clinical complications, early support, and access to specialist care.
Complications comparison
| Complication | Presentation |
|---|---|
| Cardiac involvement | Congenital heart disease is an important possible association. A specific cardiac complication pattern is not established. Echocardiography is guided by clinical findings and genetics advice. |
| Immune problems | Some patients may have immune dysfunction and infection susceptibility. No established immune-complication profile is supplied. Immunology referral depends on symptoms and test results. |
| Developmental needs | Learning, speech, behavioral, or developmental support may be needed. Support needs may vary, but their range is not well defined. Early developmental surveillance is reasonable for both. |
Patient education highlights
- HighGenetic confirmation
Neither condition should be diagnosed from appearance or symptoms alone; review the exact laboratory report with a genetics clinician.
- HighIndividualized care
Health effects depend on the genomic change and clinical findings. Lifelong or long-term specialist follow-up may be needed.
- MediumFamily planning
Parents and relatives may be offered counseling about inheritance, testing, and reproductive options.